Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2021 Should Needlestick Protocols Influence Documentation or Disclosure of a Patient’s HIV Status? Shaoli Chaudhuri, MD, MPH, Raaka Kumbhakar, MD, and Ellen Morrison, MD, MPH Heightened privacy and confidentiality stakes generate unique anonymity and nondisclosure policies and practices for HIV. AMA J Ethics. 2021;23(5):E376-381. doi: 10.1001/amajethics.2021.376. Policy Forum Nov 2017 Using Principles of Co-Production to Improve Patient Care and Enhance Value Puja Turakhia, MS and Brandon Combs, MD Improving health outcomes through patient-centered care is one way to build value for stakeholders in health care. AMA J Ethics. 2017;19(11):1125-1131. doi: 10.1001/journalofethics.2017.19.11.pfor1-1711. Original Research May 2021 Are Financial Incentives Appropriate Means of Encouraging Medication Adherence Among People Living With HIV? Toorjo Ghose, PhD, Virginia Shubert, JD, Sambuddha Chaudhuri, MBBS, PhD, Vaty Poitevien, MD, and Alison Updyke, PhD Financial incentives have been shown to improve antiretroviral adherence for people living with HIV, but some say offering them commodifies HIV care. AMA J Ethics. 2021;23(5):E394-401. doi: 10.1001/amajethics.2021.394. Viewpoint Apr 2021 Ending Restraint of Incarcerated Individuals Giving Birth Kayla Tabari House, RN, MBE, Sarah Kelley, David N. Sontag, JD, MBE, and Louise P. King, MD, JD Clinicians’ assessments of laboring women’s clinical needs must be prioritized ethically and legally. AMA J Ethics. 2021;23(4):E364-368. doi: 10.1001/amajethics.2021.364. Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542. Policy Forum Mar 2016 Graduate Medical Education Specialty Mix and Geographic Residency Program Maldistribution: Is There a Role for the ACGME? Thomas J. Nasca, MD and Douglas Carlson, JD To participate in physician workforce policy, the Accreditation Council for Graduate Medical Education must be protected from enforcement of antitrust law. AMA J Ethics. 2016;18(3):258-263. doi: 10.1001/journalofethics.2016.18.3.pfor1-1603. Case and Commentary Aug 2021 How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom? Paul T. Menzel, PhD Justification for using WTP values and QALYs lies in incorporating preferences of those whose treatment could be affected. AMA J Ethics. 2021;23(8):E601-606. doi: 10.1001/amajethics.2021.601. Case and Commentary Aug 2021 How Should Economic Value Be Considered in Treatment Decisions for Individual Patients? Hadley Stevens Smith, PhD, MPSA Physicians’ primary responsibility is to promote patients’ well-being, which includes not causing financial harm. AMA J Ethics. 2021;23(8):E607-612. doi: 10.1001/amajethics.2021.607. Medical Education Aug 2021 How Should Economic Evaluation Be Used to Measure Value and Set Priorities in Health Care? Sahan Jayawardana, MSc and Elias Mossialos, MD, PhD Novel interventions that are effective and safe but costly suggest the importance of questions about value, accessibility, and affordability. AMA J Ethics. 2021;23(8):E613-618. doi: 10.1001/amajethics.2021.613. In the Literature Aug 2021 “Perspectives” in Health Technology Assessment Anthony J. Culyer, DEcon Whether any particular perspective is the right one is contingent upon conditions in which the analysis is to be applied. AMA J Ethics. 2021;23(8):E619-623. doi: 10.1001/amajethics.2021.619. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
Case and Commentary May 2021 Should Needlestick Protocols Influence Documentation or Disclosure of a Patient’s HIV Status? Shaoli Chaudhuri, MD, MPH, Raaka Kumbhakar, MD, and Ellen Morrison, MD, MPH Heightened privacy and confidentiality stakes generate unique anonymity and nondisclosure policies and practices for HIV. AMA J Ethics. 2021;23(5):E376-381. doi: 10.1001/amajethics.2021.376.
Policy Forum Nov 2017 Using Principles of Co-Production to Improve Patient Care and Enhance Value Puja Turakhia, MS and Brandon Combs, MD Improving health outcomes through patient-centered care is one way to build value for stakeholders in health care. AMA J Ethics. 2017;19(11):1125-1131. doi: 10.1001/journalofethics.2017.19.11.pfor1-1711.
Original Research May 2021 Are Financial Incentives Appropriate Means of Encouraging Medication Adherence Among People Living With HIV? Toorjo Ghose, PhD, Virginia Shubert, JD, Sambuddha Chaudhuri, MBBS, PhD, Vaty Poitevien, MD, and Alison Updyke, PhD Financial incentives have been shown to improve antiretroviral adherence for people living with HIV, but some say offering them commodifies HIV care. AMA J Ethics. 2021;23(5):E394-401. doi: 10.1001/amajethics.2021.394.
Viewpoint Apr 2021 Ending Restraint of Incarcerated Individuals Giving Birth Kayla Tabari House, RN, MBE, Sarah Kelley, David N. Sontag, JD, MBE, and Louise P. King, MD, JD Clinicians’ assessments of laboring women’s clinical needs must be prioritized ethically and legally. AMA J Ethics. 2021;23(4):E364-368. doi: 10.1001/amajethics.2021.364.
Medicine and Society Jul 2021 How Pharmaceuticals Mask Health and Social Inequity Enrico G. Castillo, MD, MSHPM and Joel Tupper Braslow, MD, PhD Pharmaceuticals make symptoms and biological drug targets more visible but can render individual and community suffering less visible. AMA J Ethics. 2021;23(7):E542-549. doi: 10.1001/amajethics.2021.542.
Policy Forum Mar 2016 Graduate Medical Education Specialty Mix and Geographic Residency Program Maldistribution: Is There a Role for the ACGME? Thomas J. Nasca, MD and Douglas Carlson, JD To participate in physician workforce policy, the Accreditation Council for Graduate Medical Education must be protected from enforcement of antitrust law. AMA J Ethics. 2016;18(3):258-263. doi: 10.1001/journalofethics.2016.18.3.pfor1-1603.
Case and Commentary Aug 2021 How Should Willingness-to-Pay Values of Quality-Adjusted Life-Years Be Updated and According to Whom? Paul T. Menzel, PhD Justification for using WTP values and QALYs lies in incorporating preferences of those whose treatment could be affected. AMA J Ethics. 2021;23(8):E601-606. doi: 10.1001/amajethics.2021.601.
Case and Commentary Aug 2021 How Should Economic Value Be Considered in Treatment Decisions for Individual Patients? Hadley Stevens Smith, PhD, MPSA Physicians’ primary responsibility is to promote patients’ well-being, which includes not causing financial harm. AMA J Ethics. 2021;23(8):E607-612. doi: 10.1001/amajethics.2021.607.
Medical Education Aug 2021 How Should Economic Evaluation Be Used to Measure Value and Set Priorities in Health Care? Sahan Jayawardana, MSc and Elias Mossialos, MD, PhD Novel interventions that are effective and safe but costly suggest the importance of questions about value, accessibility, and affordability. AMA J Ethics. 2021;23(8):E613-618. doi: 10.1001/amajethics.2021.613.
In the Literature Aug 2021 “Perspectives” in Health Technology Assessment Anthony J. Culyer, DEcon Whether any particular perspective is the right one is contingent upon conditions in which the analysis is to be applied. AMA J Ethics. 2021;23(8):E619-623. doi: 10.1001/amajethics.2021.619.